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Background: Current adherence scales often fail to assess the full spectrum of behaviors 
associated with safe and appropriate drug use and may be unsuitable for patients with limited health 
literacy. We sought to develop and evaluate a comprehensive yet brief Measure of Drug Self-
Management (MeDS) for use in research and clinical settings among diverse patient groups.
Methods: Expert opinion, literature reviews, and interviews with patients and providers were 
utilized to create and revise potential items. Item performance testing was then conducted 
among 193 adult English-speaking patients with hypertension and diabetes. Factor analysis was 
used to inform item selection. Reliability was assessed via calculations of internal consistency. 
To assess construct and predictive validity, MeDS scores were compared with scores from the 
8-item Morisky Medication Adherence Scale and relevant clinical measures (HbA
1c
, blood 
pressure, and low-density lipoprotein cholesterol).
Results: The MeDS demonstrated adequate internal consistency with a Cronbach’s α of 0.72. 
The MeDS was significantly correlated with the Morisky Medication Adherence Scale (r= -0.62; 
P,0.001). The MeDS was also associated with clinical measures, with statistically significant 
correlations found between MeDS scores and low-density lipoprotein cholesterol (r= -0.27, 
P#0.001) and diastolic blood pressure (r= -0.18, P=0.01).
Conclusion: The MeDS seems to be a valid and reliable tool that can be used to assess medica-
tion self-management skills among diverse patients, including those with limited literacy skills. 
Future studies are needed to test the tool in actual use and explore clinical applications.
Keywords: health literacy, medication adherence, measurement
Introduction
Non-adherence to prescription drugs is highly prevalent and can jeopardize the effec-
tiveness and safety of a patient’s treatment.1–5 While estimates of non-adherence vary 
depending upon how adherence is measured and the characteristics of the drug in ques-
tion, evidence suggests that approximately half of US patients do not take medication 
as prescribed.1–5 Non-adherence is likely to contribute to more than 125,000 deaths 
annually in the USA and has long been recognized as a serious clinical concern.6 
Ensuring that patients take medications safely, appropriately, and consistently has 
therefore become a public health issue, particularly for the growing number of patients 
managing chronic diseases that require multi-drug regimens.7,8
While the importance of medication adherence is well documented, its measure-
ment remains a challenge.9 Objective assessments, such as e-monitoring, pharmacy 
claims data, and pill counts, may be useful in research, but are not as well suited to 
clinical practice. While devices like medication event monitoring system (MEMS) 
caps have advanced the measurement of medication adherence, they are often too 
costly to use in practice, especially when patients take multiple drugs. Pharmacy 
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data can be imprecise and incomplete as they only capture 
patients’ fill behaviors and can require a lengthy observa-
tion period. Pill counts can be time-intensive, cumbersome, 
and inaccurate; this methodology also requires that patients 
remember to bring their medications with them to clinic or 
research appointments.
Given these shortcomings, self-report remains the most 
common method of assessing adherence.9,10 However, com-
mon types of self-report measures, such as visual analog 
scales or patient recall of pills taken, fail to assess the full 
spectrum of behaviors a patient must undertake to effec-
tively manage medications, particularly within the context 
of multi-drug regimens.11–14 Many scales are unsuitable for 
use in clinical settings and few have been designed for use 
among patients with limited literacy skills.15,16 In this study, 
we sought to develop and evaluate a self-management scale 
that would address these shortcomings. Herein we describe 
the development and testing of the Measure of Drug Self-
Management (MeDS) among patients with multiple chronic 
conditions and complex drug regimens.
Methods
item generation
To generate potential MeDS items, we engaged in an exten-
sive and iterative process that incorporated multiple diverse 
perspectives. First, a list of potential MeDS questions was 
generated by the study team through an in-depth review of 
the scientific literature, existing measures, and expert opinion. 
Both subjective and objective questions were included to better 
reflect patients’ attitudes, beliefs, and drug use. The Health 
Literacy-Informed Model of Medication Self-Management 
was used to guide item generation and selection.17 This con-
ceptual model deconstructs the tasks associated with taking 
medications, focusing on the patient knowledge, skills, and 
behaviors needed to correctly self-administer medications in 
ambulatory care. It describes a series of six steps that patients 
must take to ensure safe, appropriate, and consistent drug use 
over time: fill, understand, organize, take, monitor, and sustain. 
A complete description of the model has been published pre-
viously.17 Investigators ensured that multiple items reflecting 
each of these steps were included for testing.
Potential items were also reviewed by physicians and 
information technology specialists during in-person meetings 
with investigators. The focus of this review was to determine 
the appropriateness and completeness of items, as well as the 
feasibility of delivering the tool in the future via an electronic 
health record (EHR) platform. Concurrent to this process, 
we also sought patient feedback on potential MeDS items. 
This was accomplished through three iterative waves of brief 
interviews and discussion groups with adult English-speaking 
patients with diabetes and hypertension (n=17). Discussion 
groups focused on reviewing potential MeDS items and 
generating ideas for improvement. Specifically, groups dis-
cussed potential items one by one and weighed in on their 
understanding of the item, providing suggestions for wording 
improvements when possible. Patients also provided opin-
ions on the content of the item, and whether they believed it 
would be relevant to their medication self-management skills. 
Patient input was used to revise potential MeDS questions 
and response options for subsequent testing. Additional items 
were also generated based upon patient suggestions.
Finally, health literacy “best practices” were applied to 
potential items to promote understanding, particularly among 
patients with limited literacy skills.18 For example, plain-
language terms and phrases were used and response options 
were simplified when possible. Drug-specific questions 
(eg, “Did you take your simvastatin yesterday?”) were also 
included in the item pool as it was theorized that such speci-
ficity would help patients answer questions more accurately, 
particularly those with low health literacy, who often have 
difficulty with vague or imprecise concepts.18 Drug-specific 
items were designed to be applicable to almost all daily use 
prescription medications.
item performance testing
To test potential MeDs items, patients were recruited from 
one large, academic general medicine clinic from June 2014 
to November 2014. They were eligible to participate if they: 
had chart diagnoses of diabetes and hypertension; were pre-
scribed at least three medications according to their medical 
record; were aged 18 years or older; were English-speaking; 
were primarily responsible for filling, organizing, and taking 
their own medication; and had no severe cognitive, vision, 
hearing, or other impairment that would preclude informed 
consent.
To recruit patients, the study was first reviewed by a 
physician committee and its approval was obtained to gen-
erate lists of potentially eligible patients (by diabetes and 
hypertension diagnoses and age) with an upcoming appoint-
ment scheduled. A research assistant then reviewed patient 
logs and approached these pre-identified patients in person 
to ask whether they would be interested in participating in 
the study. If the patient was interested, the research assistant 
verified eligibility, engaged the patient in the informed con-
sent process, and initiated a structured in-person interview. 
Patients were compensated $20 for their participation in 
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item testing activities. The institutional review board of the 
University of North Carolina at Chapel Hill approved the 
study procedures.
Measures
The study battery included 67 potential MeDS items for 
testing. As 12 of these items were drug-specific and referred 
to a particular drug in the patient’s regimen, the research 
assistant reviewed the patient’s medication list in the EHR 
prior to initiating the study interview and selected up to 
four medications to be referenced in the tool. In addition to 
MeDS items, the battery included questions regarding patient 
sociodemographic and health characteristics and the 8-item 
Morisky Medication Adherence Scale, one of the most com-
monly used self-report adherence measures.19 The validated 
Rapid Estimate of Adult Literacy in Medicine (REALM), a 
word pronunciation test, was used to assess patient literacy 
skills.20 At the conclusion of the interview, patients were 
asked questions regarding the perceived usefulness of the 
MeDS tool and potential avenues for its delivery and use 
in clinical settings. Finally, clinical measures (most recent 
HbA
1c
, diastolic and systolic blood pressure, and low-density 
lipoprotein [LDL] cholesterol) were recorded by the research 
assistant from patients’ electronic medical records.
Analyses
Simple descriptive analyses were first performed on all 
potential MeDS items, sociodemographics, clinical variables, 
and other covariates. MeDS items were screened for extreme 
ceiling effects and redundancy by examining inter-item 
correlations (ie, assessing if correlations were 0.8 or greater). 
If necessary, items were reverse-coded such that higher 
scores indicated better medication self-management skills. 
Exploratory factor analysis was used to reduce the number 
of items from the initial item pool. Specifically, principal 
component analysis with orthogonal Varimax rotation was 
employed. Several criteria were used to determine number of 
factors: scree plots, a minimum number of items (ie, at least 3) 
with high factor loadings for each potential component, and 
general interpretability of the factors. Subsequently, items 
were considered for elimination based on multiple statistical 
and theoretical aspects. In particular, items were retained for 
further analyses if their absolute values of factor loadings 
were high (ie, greater than 0.45) based upon the criteria 
proposed by Hair et al.21 Additionally, items had to show 
strong support for the theoretical interpretation of the factor 
to which they belonged. The item elimination process also 
included differential item functioning analysis to evaluate if 
selected MeDS items performed consistently across literacy 
levels, race, and age groups. To allow for detection of uni-
form and non-uniform differential item functioning, logistic 
regression was used.
In the final item elimination step, items’ contributions to 
the total scale’s internal consistency, as measured by items’ 
contributions to the value of Cronbach’s α, were assessed. 
Construct validity was assessed by examining Spearman’s 
correlations with the 8-item Morisky Medication Adherence 
Scale.19 Predictive validity was evaluated by measuring the 
correlation with patients’ most recent HbA
1c
, blood pressure, 
and LDL cholesterol measures. SAS statistical software 
version 9.3 (SAS Institute, Cary, NC, USA) was used for 
all analyses.
Results
A total of 318 patients were approached; 87 patients declined, 
33 patients were ineligible, 198 were consented, and 193 
completed the interview. Fourteen patients had missing 
or do not know responses to one or more MeDS questions 
and were consequently excluded from factor analyses, for a 
total of 179 patients. All patients were included in analyses 
of the construct and predictive validity of the tool as well as 
perceived usefulness of the measure (n=193).
Patient characteristics
Patients were diverse in terms of race, educational attainment, 
and income. The mean age of this sample was 61.1 (28–94) 
years. The majority were female (60.1%) and approximately 
half were African American (54.4%). Approximately half 
(48.7%) of participants had low or marginal literacy skills 
according to REALM. Table 1 describes the characteristics 
of the study sample (n=193). There were no significant 
differences in terms of patient characteristics between the 
sample included in factor analyses (n=179) and the total 
study sample (n=193).
item selection
Of the 67 tested MeDS items, 16 items did not correlate 
strongly (ie, measures of sampling adequacy less than 0.5) 
with other items in the matrix and therefore did not qualify for 
inclusion in further analyses. Several additional items were 
eliminated due to ceiling effects and low variability in the 
response profiles; four items were removed because they were 
repetitive with better performing items. After careful review 
of the remaining MeDS items, along with the frequencies 
of item responses, it was determined that all item responses 
could be coded dichotomously, and a matrix of tetrachoric 





correlations used in the factor analysis (n=31 items included 
in analyses). Examination of the scree plot of eigenvalues 
and factor loadings in this initial solution indicated a 3-factor 
solution. Following these analyses, additional items qualified 
for deletion because of low rotated factor loading (ie, less than 
0.45), repetition, or poor conceptual fit. No differential item 
functioning was detected with the reduced pool of items. In the 
final item elimination phase, three items having a low correla-
tion with the total scale were deleted. One item with a lower 
correlation with the total scale (#5) was retained for further 
analyses as it was conceptually important according to the 
theoretical model guiding our scale development process.
The original MeDS item pool was thus reduced to 12 final 
items, and the sum of the responses was calculated to create 
a final score. Examination of the scree plot of eigenvalues 
and factor loadings for this 12-item solution indicated that 
one factor was present, accounting for 30% of the variance. 
The mean total score of the scale was 9.4 (standard devia-
tion 2.3), while the median was 10 with a minimum of 1 
and maximum of 12. Table 2 describes the items included 
in the final scale.
reliability and validity
The total MeDS score demonstrated adequate internal con-
sistency with a Cronbach’s α of 0.72. The MeDS tool was 
significantly correlated with the 8-item Morisky Medication 
Adherence Scale (r= -0.62, P,0.001). An assessment of the 
scale’s predictive validity showed that patients with higher 
HbA
1c
, systolic blood pressure, diastolic blood pressure, 
and LDL cholesterol levels tended to demonstrate poorer 
medication self-management, with a statistically significant 
relationship found between the MeDS score and LDL cho-
lesterol (r= -0.27, P,0.001) and diastolic blood pressure 
(r= -0.18, P=0.01; Table 3).
Finalizing the tool
The final 12-item MeDS includes newly developed items as 
well as some which were derived from previously published 
scales. It includes two drug-specific questions that may be 
asked of any daily use medication in the patient’s regimen. 
All items are designed to be coded dichotomously, as either 
indicative of adequate drug self-management skills or not. 
Table 1 characteristics of study sample
Variable, n (%) Participants (n=193)
Age, mean (range) 61.1 (28–94) years
Female 116 (60.1%)
race/ethnicity




some high school or less 37 (19.2)
12th grade or geD 73 (37.8)
some college 45 (23.3)
college graduate or more 37 (19.2)











Note: All currencies are in Us$.
Abbreviation: geD, general educational Development diploma.
Table 2 Item analysis of final scale (n=179)
Mean Item-total correlation  
coefficient
Cronbach’s α if 
item is deleted
 1. Did you forget to take your (insert drug name) at any time last week? 0.82 0.47 0.68
 2. in the past month have you stopped taking (insert drug name) for any  
reason without telling your doctor?
0.90 0.31 0.71
 3. i often forget to take my medicine. 0.58 0.39 0.70
 4. i am organized about when and how i take my medicines. 0.77 0.45 0.69
 5. i have a hard time paying for my medicines. 0.61 0.19 0.72
 6. The print instructions on my prescription bottles are confusing. 0.91 0.29 0.71
 7. having to take medicines worries me. 0.80 0.35 0.70
 8. i often have a hard time remembering if i have already taken my medicine. 0.81 0.38 0.70
 9. i do not take my medicines when i am feeling sad or upset. 0.91 0.39 0.69
 10. My medicines disrupt my life. 0.93 0.31 0.71
 11. When my medicine causes minor side effects, i stop taking it. 0.68 0.38 0.70
 12. The idea of taking medications for the rest of my life makes me very  
uncomfortable.
0.73 0.31 0.71
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This allows for the final tool to be a sum of scores, ranging 
from 0 (indicating poor medication self-management) to 12 
(adequate medication self-management). The tool can also 
be used to categorize patients as having “adequate” drug self-
management skills (score of 10 or greater) or “inadequate” 
drug self-management skills (score of less than 10) based 
upon receiver operating characteristic analyses.
The final tool, including the response options and coding, 
is displayed in Figure S1. Response options for three items on 
the scale (#7, 8, and 10) were changed from “strongly agree, 
agree, disagree, strongly disagree” to “agree or disagree” after 
testing. This revision was consistent with patient preferences, 
health literacy best practices, and the distributions for these 
questions. Additionally, one item (#3), originally worded 
as “How often do you forget to take your medicine?”, was 
reworded to “I often forget to take my medicine” in order to 
be consistent with the phrasing of other questions included 
in the scale.
Patients’ perceived usefulness of the 
MeDs and avenues for delivery
Most participants (88.1%; n=193) reported that they would be 
willing to answer a brief set of questions about their medica-
tion use before each clinic visit. A subset of these patients 
(72.6%) also reported that they would be able and willing 
to complete the MeDS tool online before coming for their 
visit. Of the 21 patients who were not willing to complete 
the final MeDS tool, five attributed this to time constraints, 
nine listed the inconvenience involved with surveys, and 
seven believed that the tool would have no benefit because 
they were adherent to their medicines. Overall, 88.6% of the 
participants interviewed believed that this tool could help 
them or other patients to take their medicines safely.
Discussion
Findings from this study indicate that the MeDS is a valid and 
reliable measure of patient self-management skills. The tool 
was developed using an extensive process that incorporated 
patient, physician, and expert opinions; health literacy best 
practices were also considered in the design of items and 
response options.18 Psychometric testing revealed adequate 
internal consistency and statistically significant correlations 
with the 8-item Morisky Medication Adherence Scale and 
meaningful clinical measures, including LDL cholesterol 
and diastolic blood pressure.
While numerous adherence measures exist, the MeDS is 
unique in its use of objective and subjective items addressing 
various patient behaviors and abilities that are essential for 
effective medication self-management (ie, filling a prescrip-
tion, understanding directions for use, taking medications, 
organizing a regimen, monitoring side effects, and sustain-
ing use over time).17 It is also notable as it was developed 
incorporating patient and provider perspectives and health 
literacy best practices; the resulting tool is written at a 
6th grade reading level and is easy to use among diverse 
patient populations. Patient feedback on the tool suggests that 
patients would be willing to complete the assessment prior to 
a clinic visit and find value in such a tool. Thus, the MeDS 
may have both clinical and research applications.
This study has limitations that should be noted. First, it was 
conducted at one site among English-speaking, predominantly 
African American and White patients, which may limit its 
generalizability. As the MeDS tool relies upon patient self-
report, it is possible that results are not reflective of actual 
medication use due to social desirability bias or patient mis-
interpretation of items; this, however, is true for all self-report 
measures. As the tool includes two drug-specific questions, it 
requires knowledge of the patient’s prescribed drug regimen. 
However, we chose to include drug-specific questions as we 
theorized that they would provide more accurate responses, 
particularly among patients with low health literacy, who often 
have trouble with vague or imprecise concepts.18 It is also 
possible that the drug-specific questions may not be suitable 
for all drugs (ie, medicines prescribed pro re nata [PRNs]).
While in this study the MeDS tool was completed with the 
help of a research assistant, the tool was ultimately designed 
to be linked to an EHR to allow for clinical application. 
We therefore sought input from information technology 
specialists to ensure that drug-specific questions could be 
automatically populated from EHR fields containing drug 
Table 3 internal consistency, construct validity, and predictive validity for the Measure of Drug self-Management
Internal consistency Construct validity Predictive validity 
Correlation (P-value) Correlation (P-value)




HbA1C Systolic BP Diastolic BP LDL levels
0.72 0.19–0.47 -0.62 (,0.001) -0.07 (0.35) -0.09 (0.19) -0.18 (0.01) -0.27 (,0.001)
Abbreviations: BP, blood pressure; lDl, low-density lipoprotein





names, dosages, and corresponding instructions (also known 
as “sigs”). If successfully linked to an EHR, the MeDS tool 
could be used to routinely assess patient medication self-
management skills and help identify those patients in need 
of further intervention. This is important, as physicians rarely 
utilize standardized means of assessing adherence; evidence 
also suggests that physicians’ clinical judgment of patient 
adherence is often inaccurate.22 A study conducted by Gilbert 
et al found that the sensitivity of the primary care physician’s 
clinical judgment for detecting non-adherence was only 
10%; other studies have similarly shown that physicians and 
nurses overestimate patient literacy skills, which are likely to 
influence their medication management capabilities.23–25 The 
MeDs could therefore serve as a valuable tool that would help 
standardize how adherence is assessed, helping to initially 
detect patients who may be struggling with medication use 
and could possibly benefit from further, more advanced 
intervention such as medication therapy management.
While medication non-adherence is a highly recognized 
public health and patient safety concern, current adherence 
measures often do not assess the full spectrum of knowledge 
and behaviors necessary to successfully take medication 
in outpatient settings. Findings from our evaluation of the 
MeDS indicate that the measure is predictive of meaningful 
clinical outcomes and that patients are supportive of its use 
in clinical practice. Further resources are needed to link the 
MeDS to EHR platforms and to test the tool in actual use.
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We would like to ask you a few questions to make sure you are taking your medicine safely. The first two questions are about specific 
medications that you may be taking.
   1. Did you forget to take your (insert drug 1 name) at any time last week?
   Yes .......................................................................................................................................................................................................0
   No .........................................................................................................................................................................................................1
   I do not know ........................................................................................................................................................................................0
   2. In the past month, have you stopped taking (insert drug 2 name) for any reason without telling your doctor?
   Yes .......................................................................................................................................................................................................0
   No .........................................................................................................................................................................................................1
   I do not know ........................................................................................................................................................................................0
For the next set of questions, please tell us how often the following statements are true for you.
   3. I often forget to take my medicine.
   Never ....................................................................................................................................................................................................1
   Some of the time ..................................................................................................................................................................................0
   Most of the time ....................................................................................................................................................................................0
   All of the time ........................................................................................................................................................................................0
   4. I am organized about when and how I take my medicines.
   Never ....................................................................................................................................................................................................0
   Some of the time ..................................................................................................................................................................................0
   Most of the time ....................................................................................................................................................................................0
   All of the time ........................................................................................................................................................................................1
   5. I have a hard time paying for my medicines.
   Never ....................................................................................................................................................................................................1
   Some of the time ..................................................................................................................................................................................0
   Most of the time ................................................................................................................................................................................... 0
   All of the time ........................................................................................................................................................................................0
For the last set of questions, please tell us if you agree or disagree with the following statements.
   6. The print instructions on my prescription bottles are confusing.
   Agree ....................................................................................................................................................................................................0
  Disagree ...............................................................................................................................................................................................1
   7. Having to take medicines worries me.
   Agree ....................................................................................................................................................................................................0
   Disagree ...............................................................................................................................................................................................1
   8. I often have a hard time remembering if I have already taken my medicine.
   Agree ....................................................................................................................................................................................................0
   Disagree ...............................................................................................................................................................................................1
   9. I do not take my medicines when I am feeling sad or upset.
   Agree ....................................................................................................................................................................................................0
   Disagree ...............................................................................................................................................................................................1
 10. My medicines disrupt my life.
   Agree ....................................................................................................................................................................................................0
  Disagree ...............................................................................................................................................................................................1
 11. When my medicine causes minor side effects, I stop taking it.
   Agree ....................................................................................................................................................................................................0
   Disagree ...............................................................................................................................................................................................1
 12. The idea of taking medications for the rest of my life makes me very uncomfortable.
   Agree ....................................................................................................................................................................................................0
   Disagree ...............................................................................................................................................................................................1
Figure S1 Measure of Drug self-Management (MeDs).
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